EchoGo® Heart Failure vs Study Watch
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
EchoGo® Heart Failure is an AI platform designed for rapid diagnosis of HFpEF by analyzing routine echocardiograms, providing clinical decision support. In contrast, Verily Study Watch is a wearable device for continuous physiological monitoring, primarily used to collect data for clinical research. While both fall under Cardiology AI, their core functions diverge significantly, with one focusing on diagnostic insights and the other on research-grade data collection.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is an AI platform designed to analyze routine echocardiograms for the detection of Heart Failure with preserved Ejection Fraction (HFpEF), providing insights to support clinical decisions. Study Watch is a prescription-only, sensor-based wearable device primarily used for non-invasive, continuous physiological monitoring in clinical research, collecting data such as ECG and heart rate.
EchoGou00ae Heart Failure analyzes routine echo video clips using AI to generate insights within 20 minutes. Study Watch collects continuous physiological data via multiple sensors on a wearable device, which is then uploaded to Verily's cloud platform for processing with algorithms and machine learning.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. Pricing for Study Watch is not publicly available as it is a device for clinical research and partnerships, and thus reimbursement details are not provided for general clinical use.
EchoGou00ae Heart Failure delivers AI-powered HFpEF detection insights within 20 minutes and generates automated structured reports, with report delivery to PACS via DICOM workflow. Study Watch uploads physiological data to a cloud platform and offers features like on-demand single-channel ECG and an irregular pulse monitor, primarily for analysis in clinical research.
EchoGou00ae Heart Failure is designed for seamless integration with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery to PACS. Study Watch is a wearable device that uploads collected data to Verily's cloud platform for processing, implying a cloud-based data management approach rather than direct integration with on-premise clinical IT stacks for real-time decision support.
EchoGou00ae Heart Failure is clinically validated, demonstrating 90% sensitivity and 86% specificity for HFpEF detection, and was trained on over 10 years of outcome data. While Study Watch is FDA-cleared for continuous physiological monitoring in clinical research, specific clinical validation metrics for diagnostic accuracy in a general clinical setting are not provided, as its primary purpose is data collection for research.